EPE is demonstrated to protect from diabetic nephropathy by its maker component chebulagic acid with an antiangiogenic effect involved in VEGF inhibition and anti-inflammatory in db/db mice [55]. The gene discussed is VEGFA; the disease is diabetic kidney disease.